You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PgR

Showing 1 - 25 of 178
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Montpellier (Letrozole - Concomitant, Letrozole - Sequential)

Completed
  • Breast Cancer
  • Letrozole - Concomitant
  • Letrozole - Sequential
  • Montpellier, France
    CRLC Val d'Aurelle
Jun 1, 2021

Breast Cancer Trial in Phoenix, Zion, Nashville (Elacestrant, Onapristone)

Recruiting
  • Breast Cancer
  • Phoenix, Arizona
  • +2 more
Jan 20, 2023

ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer Trial in Madison, Milwaukee (Onapristone, Fulvestrant)

Recruiting
  • ER-positive Breast Cancer
  • +2 more
  • Madison, Wisconsin
  • +1 more
Jul 7, 2022

Type 2 Diabetes Trial in Naples (Test meal with postprandial samples)

Recruiting
  • Type 2 Diabetes
  • Test meal with postprandial samples
  • Naples, Italy
    Department of Clinical Medicine and Surgery Federico II Universi
Sep 20, 2023

Breast Cancer Trial in Barcelona, Lleida, Tarragona (Onapristone)

Completed
  • Breast Cancer
  • Barcelona, Spain
  • +3 more
Mar 31, 2022

Breast Cancer Trial (Utidelone Injection in combination with AC, Docetaxel Injection in combination with AC)

Not yet recruiting
  • Breast Cancer
  • Utidelone Injection in combination with AC
  • Docetaxel Injection in combination with AC
  • (no location specified)
Jan 10, 2023

Breast Cancer Trial in Spain (Alpelisib, Metformin, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Alicante, Spain
  • +17 more
Aug 23, 2022

Postprandial Glucose Response in Type 1 Diabetes

Recruiting
  • Type 1 Diabetes
    • Naples, Italy
      Federico II University Hospital
    Jun 30, 2023

    Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313

    Completed
    • Breast Cancer
    • gene expression analysis
    • +3 more
    • New Haven, Connecticut
      Yale Cancer Center
    Dec 18, 2019

    Breast Tumors Trial in Spain (No intervention)

    Recruiting
    • Breast Neoplasms
    • No intervention
    • Elche, Alicante, Spain
    • +39 more
    Jan 20, 2023

    Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

    Recruiting
    • Carcinoma, Ovarian Epithelial
    • Low Grade Serous Adenocarcinoma of Ovary
    • Letrozole tablets
    • carboplatin AUC 5 and paclitaxel 175 mg/m2
    • Brescia, BS, Italy
    • +1 more
    Oct 26, 2022

    Visual Stress Trial in Cambridge (Tinted Lenses)

    Recruiting
    • Visual Stress
    • Tinted Lenses
    • Cambridge, United Kingdom
      Anglis Ruskin University
    Oct 19, 2023

    Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Birmingham, Alabama
    • +7 more
    May 15, 2022

    HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive Trial in United States (procedure, drug,

    Active, not recruiting
    • HER2/Neu Negative
    • +3 more
    • Computed Tomography
    • +3 more
    • Birmingham, Alabama
    • +24 more
    Jan 27, 2023

    Real-World Data of Clinicopathological Characteristics and

    Recruiting
    • Early Breast Cancer
    • +2 more
      • Barcelona, Spain
      • +9 more
      Jan 18, 2023

      Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma Trial in Madison (18F-fluorofuranylnorprogesterone, Liquid Biopsy,

      Recruiting
      • Metastatic Cancer
      • +2 more
      • Madison, Wisconsin
        UW Carbone Cancer Center
      Oct 10, 2023

      Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

      Not yet recruiting
      • Breast Atypical Hyperplasia
      • +3 more
      • Acolbifene Hydrochloride
      • +4 more
      • Duarte, California
      • +3 more
      Jul 11, 2023

      HER2-negative Breast Cancer Trial in Georgia, Mexico, United Kingdom (AZD9833)

      Recruiting
      • HER2-negative Breast Cancer
      • Batumi, Georgia
      • +18 more
      Jan 13, 2023

      Breast Cancer Trial in Worldwide (Abraxane, Paclitaxel)

      Active, not recruiting
      • Breast Cancer
      • Adelaide, South Australia, Australia
      • +66 more
      Aug 10, 2022

      CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67

      Completed
      • Invasive Breast Cancer
      • immunohistochemistry and/or FISH
      • Beijing, Beijing, China
        Peking University Cancer Hospital
      Jan 16, 2019

      HER2-negative Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in Spain (Olaparib)

      Recruiting
      • HER2-negative Breast Cancer
      • +2 more
      • Barcelona, Spain
      • +4 more
      Apr 14, 2022

      Breast Cancer Trial in Norway (drug, procedure, radiation)

      Active, not recruiting
      • Breast Cancer
      • Neoadjuvant tamoxifen + goserelin (premenopausal women)
      • +15 more
      • Lørenskog, Akershus, Norway
      • +6 more
      Aug 24, 2021

      Investigating the Effects of Iron on the Gastrointestinal Tract

      Not yet recruiting
      • Iron Deficiency Anemia
      • Constipation
      • Fasted breath samples
      • +3 more
      • Sheffield, United Kingdom
        Sheffield Teaching Hospitals
      Oct 18, 2022

      Type 2 Diabetes Trial in Berkeley (Coffee)

      Recruiting
      • Type 2 Diabetes
      • Coffee
      • Berkeley, California
        Kaiser Permanente
      Jan 24, 2023

      Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

      Recruiting
      • Advanced Breast Cancer
      • Thalassery, Kerala, India
        Novartis Investigative Site
      Nov 21, 2022